364 related articles for article (PubMed ID: 25977408)
1. Nicotine Metabolite Ratio Is Associated With Lozenge Use But Not Quitting in Smokeless Tobacco Users.
Ebbert JO; Severson HH; Danaher BG; Benowitz NL; Schroeder DR
Nicotine Tob Res; 2016 Mar; 18(3):366-70. PubMed ID: 25977408
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of nicotine lozenges and phone counseling for smokeless tobacco cessation.
Severson HH; Danaher BG; Ebbert JO; van Meter N; Lichtenstein E; Widdop C; Crowley R; Akers L; Seeley JR
Nicotine Tob Res; 2015 Mar; 17(3):309-15. PubMed ID: 25168034
[TBL] [Abstract][Full Text] [Related]
3. Nicotine lozenges for the treatment of smokeless tobacco use.
Ebbert JO; Dale LC; Severson H; Croghan IT; Rasmussen DF; Schroeder DR; Vander Weg MW; Hurt RD
Nicotine Tob Res; 2007 Feb; 9(2):233-40. PubMed ID: 17365754
[TBL] [Abstract][Full Text] [Related]
4. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
[TBL] [Abstract][Full Text] [Related]
5. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
[TBL] [Abstract][Full Text] [Related]
6. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of the nicotine lozenge and tobacco-free snuff for smokeless tobacco reduction.
Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
Addict Behav; 2013 May; 38(5):2140-5. PubMed ID: 23454876
[TBL] [Abstract][Full Text] [Related]
8. Influence of Nicotine Metabolism Ratio on [11C]-(+)-PHNO PET Binding in Tobacco Smokers.
Di Ciano P; Tyndale RF; Mansouri E; Hendershot CS; Wilson AA; Lagzdins D; Houle S; Boileau I; Le Foll B
Int J Neuropsychopharmacol; 2018 Jun; 21(6):503-512. PubMed ID: 29346545
[TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of nicotine lozenge for smokeless tobacco use.
Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
Nicotine Tob Res; 2009 Dec; 11(12):1415-23. PubMed ID: 19880578
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of mailed nicotine lozenges with assisted self-help for the treatment of smokeless tobacco users.
Ebbert JO; Severson HH; Croghan IT; Danaher BG; Schroeder DR
Addict Behav; 2010 May; 35(5):522-5. PubMed ID: 20060229
[TBL] [Abstract][Full Text] [Related]
11. Nicotine metabolite ratio predicts smoking topography: The Pennsylvania Adult Smoking Study.
Chen A; Krebs NM; Zhu J; Muscat JE
Drug Alcohol Depend; 2018 Sep; 190():89-93. PubMed ID: 29990649
[TBL] [Abstract][Full Text] [Related]
12. Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India.
Jain R; Jhanjee S; Jain V; Gupta T; Mittal S; Chauhan P; Raghav R; Goelz P; Schnoll RA
J Psychoactive Drugs; 2015; 47(4):331-5. PubMed ID: 26317285
[TBL] [Abstract][Full Text] [Related]
13. Nicotine Metabolism in Young Adult Daily Menthol and Nonmenthol Smokers.
Fagan P; Pokhrel P; Herzog TA; Pagano IS; Franke AA; Clanton MS; Alexander LA; Trinidad DR; Sakuma KL; Johnson CA; Moolchan ET
Nicotine Tob Res; 2016 Apr; 18(4):437-46. PubMed ID: 25995160
[TBL] [Abstract][Full Text] [Related]
14. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy.
Jacob P; Hatsukami D; Severson H; Hall S; Yu L; Benowitz NL
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1668-73. PubMed ID: 12496059
[TBL] [Abstract][Full Text] [Related]
15. Smokeless tobacco abstinence effects and nicotine gum dose.
Hatsukami D; Anton D; Keenan R; Callies A
Psychopharmacology (Berl); 1992; 106(1):60-6. PubMed ID: 1738794
[TBL] [Abstract][Full Text] [Related]
16. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study.
Andersson G; Björnberg G; Curvall M
J Oral Pathol Med; 1994 Apr; 23(4):161-7. PubMed ID: 8046653
[TBL] [Abstract][Full Text] [Related]
17. Effects of Nicotine Metabolic Rate on Cigarette Reinforcement.
Liakoni E; Nardone N; St Helen G; Dempsey DA; Tyndale RF; Benowitz NL
Nicotine Tob Res; 2020 Jul; 22(8):1419-1423. PubMed ID: 31725872
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Salivary Cotinine Concentrations in Male Smokers and Smokeless Tobacco Users.
Honarmand M; Nakhaee A; Moradi M
Asian Pac J Cancer Prev; 2018 May; 19(5):1363-1366. PubMed ID: 29802701
[TBL] [Abstract][Full Text] [Related]
19. The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.
Chenoweth MJ; Schnoll RA; Novalen M; Hawk LW; George TP; Cinciripini PM; Lerman C; Tyndale RF
Nicotine Tob Res; 2016 Apr; 18(4):491-5. PubMed ID: 26069034
[TBL] [Abstract][Full Text] [Related]
20. Levels of saliva cotinine in electronic cigarette users.
Etter JF
Addiction; 2014 May; 109(5):825-9. PubMed ID: 24401004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
